{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T17:03:49Z","timestamp":1772816629907,"version":"3.50.1"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T00:00:00Z","timestamp":1585872000000},"content-version":"am","delay-in-days":277,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 HD29787"],"award-info":[{"award-number":["P01 HD29787"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-13-0053"],"award-info":[{"award-number":["W81XWH-13-0053"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.nbd.2019.03.029","type":"journal-article","created":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T18:53:02Z","timestamp":1553712782000},"page":"390-397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["NitroSynapsin for the treatment of neurological manifestations of tuberous sclerosis complex in a rodent model"],"prefix":"10.1016","volume":"127","author":[{"given":"Shu-ichi","family":"Okamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Prikhodko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Pina-Crespo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Adame","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott R.","family":"McKercher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence M.","family":"Brill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuki","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-ki","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliezer","family":"Masliah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart A.","family":"Lipton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2019.03.029_bb0005","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10242","article-title":"Elevated glucose and oligomeric beta-amyloid disrupt synapses via a common pathway of aberrant protein S-nitrosylation","volume":"7","author":"Akhtar","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2019.03.029_bb0010","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.neuron.2018.12.026","article-title":"Increased excitation-inhibition ratio stabilizes synapse and circuit excitability in four autism mouse models","volume":"101","author":"Antoine","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2019.03.029_bb0015","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nature10658","article-title":"Mutations causing syndromic autism define an axis of synaptic pathophysiology","volume":"480","author":"Auerbach","year":"2011","journal-title":"Nature."},{"key":"10.1016\/j.nbd.2019.03.029_bb0020","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.neuron.2013.03.017","article-title":"Excitatory\/inhibitory synaptic imbalance leads to hippocampal hyperexcitability in mouse models of tuberous sclerosis","volume":"78","author":"Bateup","year":"2013","journal-title":"Neuron."},{"key":"10.1016\/j.nbd.2019.03.029_bb0025","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1073\/pnas.87.4.1620","article-title":"Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide","volume":"87","author":"Beckman","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2019.03.029_bb0030","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neuroscience.2008.06.073","article-title":"Cellular localization of metabotropic glutamate receptors in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex","volume":"156","author":"Boer","year":"2008","journal-title":"Neuroscience."},{"key":"10.1016\/j.nbd.2019.03.029_bb0035","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/brain\/awf124","article-title":"Neuro-epileptic determinants of autism spectrum disorders in tuberous sclerosis complex","volume":"125","author":"Bolton","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2019.03.029_bb0040","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nature09582","article-title":"Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes","volume":"468","author":"Chao","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2019.03.029_bb0045","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1113\/jphysiol.1997.sp021909","article-title":"Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: uncompetitive antagonism","volume":"499","author":"Chen","year":"1997","journal-title":"J. Physiol."},{"key":"10.1016\/j.nbd.2019.03.029_bb0050","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1523\/JNEUROSCI.12-11-04427.1992","article-title":"Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity","volume":"12","author":"Chen","year":"1992","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.03.029_bb0055","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.nbd.2011.07.018","article-title":"Impaired social interactions and motor learning skills in tuberous sclerosis complex model mice expressing a dominant\/negative form of tuberin","volume":"45","author":"Chevere-Torres","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2019.03.029_bb0060","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1177\/0883073807302611","article-title":"Memantine as adjunctive therapy in children diagnosed with autistic spectrum disorders: an observation of initial clinical response and maintenance tolerability","volume":"22","author":"Chez","year":"2007","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.nbd.2019.03.029_bb0065","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/71090","article-title":"Molecular basis of NMDA receptor-coupled ion channel modulation by S-nitrosylation","volume":"3","author":"Choi","year":"2000","journal-title":"Nat. Neurosci."},{"issue":"7","key":"10.1016\/j.nbd.2019.03.029_bb2005","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1038\/sj.npp.1301535","article-title":"Acute injections of the NMDA receptor antagonist memantine rescue performance deficits of the Ts65Dn mouse model of Down syndrome on a fear conditioning test","volume":"33","author":"Costa","year":"2008","journal-title":"Neuropsychopharmacol."},{"key":"10.1016\/j.nbd.2019.03.029_bb0070","doi-asserted-by":"crossref","first-page":"6368","DOI":"10.1073\/pnas.88.14.6368","article-title":"Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures","volume":"88","author":"Dawson","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2019.03.029_bb0075","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00787-006-0570-3","article-title":"The psychopathologies of children and adolescents with tuberous sclerosis complex (TSC): a postal survey of UK families","volume":"16","author":"de Vries","year":"2007","journal-title":"Eur. Child. Adolesc. Psychiatry"},{"key":"10.1016\/j.nbd.2019.03.029_bb0080","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/ajmg.a.32690","article-title":"Neuropsychological attention deficits in tuberous sclerosis complex (TSC)","volume":"149a","author":"de Vries","year":"2009","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.nbd.2019.03.029_bb0085","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1038\/ncomms5701","article-title":"The MK2\/3 cascade regulates AMPAR trafficking and cognitive flexibility","volume":"5","author":"Eales","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2019.03.029_bb0090","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10519-010-9398-1","article-title":"Increased levels of anxiety-related behaviors in a Tsc2 dominant negative transgenic mouse model of tuberous sclerosis","volume":"41","author":"Ehninger","year":"2011","journal-title":"Behav. Genet."},{"key":"10.1016\/j.nbd.2019.03.029_bb0095","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1788","article-title":"Reversal of learning deficits in a Tsc2+\/\u2212 mouse model of tuberous sclerosis","volume":"14","author":"Ehninger","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2019.03.029_bb0100","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1124\/mol.113.089334","article-title":"Indistinguishable synaptic pharmacodynamics of the N-methyl-D-aspartate receptor channel blockers memantine and ketamine","volume":"84","author":"Emnett","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.nbd.2019.03.029_bb0105","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s40263-015-0252-0","article-title":"Developing medications targeting glutamatergic dysfunction in autism: progress to date","volume":"29","author":"Fung","year":"2015","journal-title":"CNS Drugs"},{"key":"10.1016\/j.nbd.2019.03.029_bb0110","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1523\/JNEUROSCI.22-10-04015.2002","article-title":"Caspase cascades in human immunodeficiency virus-associated neurodegeneration","volume":"22","author":"Garden","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.03.029_bb0115","doi-asserted-by":"crossref","first-page":"31913","DOI":"10.1074\/jbc.R110.154476","article-title":"Translational control mechanisms in long-lasting synaptic plasticity and memory","volume":"285","author":"Gkogkas","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2019.03.029_bb0120","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/ana.21317","article-title":"Cognitive deficits in Tsc1+\/\u2212 mice in the absence of cerebral lesions and seizures","volume":"62","author":"Goorden","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2019.03.029_bb0125","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/nature12630","article-title":"SHANK3 overexpression causes manic-like behaviour with unique pharmacogenetic properties","volume":"503","author":"Han","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2019.03.029_bb0130","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.neuron.2014.01.016","article-title":"Enhancement of inhibitory neurotransmission by GABAA receptors having alpha2,3-subunits ameliorates behavioral deficits in a mouse model of autism","volume":"81","author":"Han","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2019.03.029_bb0135","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nrn2911","article-title":"Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders","volume":"11","author":"Hardingham","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2019.03.029_bb0140","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nn835","article-title":"Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways","volume":"5","author":"Hardingham","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2019.03.029_bb0145","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/(SICI)1096-8628(19991215)88:6<642::AID-AJMG12>3.0.CO;2-O","article-title":"Cognitive deficits in normally intelligent patients with tuberous sclerosis","volume":"88","author":"Harrison","year":"1999","journal-title":"Am. J. Med. Genet."},{"issue":"4","key":"10.1016\/j.nbd.2019.03.029_bb0150","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1212\/CPJ.0000000000000260","article-title":"Tuberous sclerosis complex: five new things","volume":"6","author":"Hsieh","year":"2016","journal-title":"Neurol. Clin. Pract."},{"key":"10.1016\/j.nbd.2019.03.029_bb0155","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/ana.22070","article-title":"Erythropoietin plus insulin-like growth factor-I protects against neuronal damage in a murine model of human immunodeficiency virus-associated neurocognitive disorders","volume":"68","author":"Kang","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2019.03.029_bb0160","article-title":"High-throughput sequencing of mGluR signaling pathway genes reveals enrichment of rare variants in autism","volume":"7","author":"Kelleher","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2019.03.029_bb0165","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/0896-6273(92)90130-6","article-title":"Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex","volume":"8","author":"Lei","year":"1992","journal-title":"Neuron."},{"key":"10.1016\/j.nbd.2019.03.029_bb0170","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/jmg.2003.012757","article-title":"Genotype and psychological phenotype in tuberous sclerosis","volume":"41","author":"Lewis","year":"2004","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.nbd.2019.03.029_bb0175","doi-asserted-by":"crossref","first-page":"9397","DOI":"10.1073\/pnas.0802876105","article-title":"Transcription factor MEF2C influences neural stem\/progenitor cell differentiation and maturation in vivo","volume":"105","author":"Li","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2019.03.029_bb0180","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/nrd1958","article-title":"Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond","volume":"5","author":"Lipton","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.nbd.2019.03.029_bb0185","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nrn2229","article-title":"Pathologically activated therapeutics for neuroprotection","volume":"8","author":"Lipton","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2019.03.029_bb0190","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/364626a0","article-title":"A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds","volume":"364","author":"Lipton","year":"1993","journal-title":"Nature."},{"key":"10.1016\/j.nbd.2019.03.029_bb0195","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.1038\/ncomms5563","article-title":"Selective suppression of excessive GluN2C expression rescues early epilepsy in a tuberous sclerosis murine model","volume":"5","author":"Lozovaya","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2019.03.029_bb0200","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fphar.2013.00024","article-title":"Selective pharmacological modulation of pyramidal neurons and interneurons in the CA1 region of the rat hippocampus","volume":"4","author":"Martina","year":"2013","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.nbd.2019.03.029_bb0205","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.yebeh.2007.07.010","article-title":"Psychiatric comorbid conditions in a clinic population of 241 patients with tuberous sclerosis complex","volume":"11","author":"Muzykewicz","year":"2007","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.nbd.2019.03.029_bb0210","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nn.2477","article-title":"Tsc2-Rheb signaling regulates EphA-mediated axon guidance","volume":"13","author":"Nie","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2019.03.029_bb0215","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/nm.2056","article-title":"Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin","volume":"15","author":"Okamoto","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2019.03.029_bb0220","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1172\/JCI7319","article-title":"Tsc2(+\/\u2212) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background","volume":"104","author":"Onda","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2019.03.029_bb0225","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.neuron.2014.03.030","article-title":"Extrasynaptic NMDA receptor involvement in central nervous system disorders","volume":"82","author":"Parsons","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2019.03.029_bb0230","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.cell.2011.08.040","article-title":"Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits","volume":"147","author":"Penagarikano","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2019.03.029_bb0235","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1177\/08830738040190090601","article-title":"Behavioral and cognitive aspects of tuberous sclerosis complex","volume":"19","author":"Prather","year":"2004","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.nbd.2019.03.029_bb0240","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.yebeh.2007.02.004","article-title":"Psychological profile of adults with tuberous sclerosis complex","volume":"10","author":"Pulsifer","year":"2007","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.nbd.2019.03.029_bb0245","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2788.2006.00828.x","article-title":"Psychopathology in tuberous sclerosis: an overview and findings in a population-based sample of adults with tuberous sclerosis","volume":"50","author":"Raznahan","year":"2006","journal-title":"J. Intellect. Disabil. Res."},{"key":"10.1016\/j.nbd.2019.03.029_bb0250","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/cercor\/bhj144","article-title":"Neuroanatomical correlates of memory deficits in tuberous sclerosis complex","volume":"17","author":"Ridler","year":"2007","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.nbd.2019.03.029_bb0255","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00702-014-1216-0","article-title":"The role of glutamate and its receptors in autism and the use of glutamate receptor antagonists in treatment","volume":"121","author":"Rojas","year":"2014","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.nbd.2019.03.029_bb0260","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.stemcr.2016.07.019","article-title":"Quantitative analysis of human pluripotency and neural specification by in-depth (Phospho)proteomic profiling","volume":"7","author":"Singec","year":"2016","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.nbd.2019.03.029_bb0265","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1023\/A:1026052421693","article-title":"Autism and tuberous sclerosis","volume":"28","author":"Smalley","year":"1998","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.nbd.2019.03.029_bb0270","doi-asserted-by":"crossref","DOI":"10.1038\/srep14781","article-title":"Pharmacologically targeted NMDA receptor antagonism by NitroMemantine for cerebrovascular disease","volume":"5","author":"Takahashi","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2019.03.029_bb0275","doi-asserted-by":"crossref","first-page":"E2518","DOI":"10.1073\/pnas.1306832110","article-title":"Abeta induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss","volume":"110","author":"Talantova","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.nbd.2019.03.029_bb2000","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/ana.21342","article-title":"Cell-specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubers","volume":"63","author":"Talos","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2019.03.029_bb0280","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.neuron.2014.07.040","article-title":"Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits","volume":"83","author":"Tang","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2019.03.029_bb0285","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1038\/nn1566","article-title":"Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2","volume":"8","author":"Tavazoie","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2019.03.029_bb0290","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1471-4159.2005.03538.x","article-title":"Enhanced episodic-like memory and kindling epilepsy in a rat model of tuberous sclerosis","volume":"96","author":"Waltereit","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2019.03.029_bb0295","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2174\/156720506777632808","article-title":"The pharmacology of aminoadamantane nitrates","volume":"3","author":"Wang","year":"2006","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.nbd.2019.03.029_bb0300","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/ana.10648","article-title":"Impaired glial glutamate transport in a mouse tuberous sclerosis epilepsy model","volume":"54","author":"Wong","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2019.03.029_bb0305","doi-asserted-by":"crossref","first-page":"11246","DOI":"10.1523\/JNEUROSCI.2488-10.2010","article-title":"Memantine preferentially blocks extrasynaptic over synaptic NMDA receptor currents in hippocampal autapses","volume":"30","author":"Xia","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.03.029_bb0310","doi-asserted-by":"crossref","first-page":"52ra73","DOI":"10.1126\/scitranslmed.3001059","article-title":"PGC-1alpha, a potential therapeutic target for early intervention in Parkinson's disease","volume":"2","author":"Zheng","year":"2010","journal-title":"Sci. Transl. Med."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996119300804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996119300804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:18:39Z","timestamp":1760851119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996119300804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":64,"alternative-id":["S0969996119300804"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2019.03.029","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NitroSynapsin for the treatment of neurological manifestations of tuberous sclerosis complex in a rodent model","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2019.03.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}